Nazila Bahmaie | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Nazila Bahmaie | Immunology and Microbiology | Best Researcher Award

clinical research assistant at Ankara Yildirim Beyazit University, Turkey

Nazila Bahmaie is a dedicated researcher and PhD candidate specializing in Cancer Biology. Born in Ahvaz, Iran, on December 21, 1990, she has pursued an academic and research career across multiple countries, including Iran, Cyprus, and Turkey. Currently enrolled at Ankara Yildirim Beyazit University in Turkey, Nazila is focused on advancing her expertise in cancer biology. Her international academic experience has allowed her to engage with diverse research methodologies, enhancing her scientific adaptability. With a deep commitment to biomedical research, she aims to contribute to groundbreaking discoveries in cancer treatment and immunology. Nazila’s extensive background in medical sciences reflects her passion for understanding complex biological processes and her dedication to improving global healthcare outcomes.

Professional Profile

Education

Nazila Bahmaie has an impressive academic background, with degrees in cellular and molecular biology, medical microbiology, and immunology. She completed her BSc in Cellular and Molecular Biology, majoring in Microbiology, at Maragheh University in Iran, followed by an MSc in Medical Microbiology and Immunology at Zanjan University of Medical Sciences, where she graduated with distinction. Continuing her academic journey, she pursued a PhD in Immunology and Allergy at Near East University in Cyprus before transferring to her current PhD program in Cancer Biology at Ankara Yildirim Beyazit University in Turkey. Her educational trajectory demonstrates a consistent focus on biology and medical sciences, with an emphasis on translational research that bridges basic science and clinical applications.

Professional Experience

Nazila Bahmaie’s professional journey includes significant research roles in cancer biology, immunology, and medical microbiology. As a PhD candidate at Ankara Yildirim Beyazit University, she conducts cancer research under the guidance of prominent scientists, focusing on cancer biology and immunological mechanisms. Before this, she contributed to the field of immunology during her PhD fellowship at Near East University, where she explored pediatric immunology and allergy. Nazila has also worked in medical microbiology, conducting essential research during her MSc studies at Zanjan University of Medical Sciences. Her professional experiences have equipped her with diverse research skills, including cellular and molecular techniques, and a deep understanding of immune responses in diseases.

Research Interests

Nazila Bahmaie’s research interests are focused on the intersection of cancer biology and immunology, particularly in understanding the molecular mechanisms that drive cancer progression and how the immune system can be leveraged to treat cancers. She is deeply involved in studying the immune responses in cancer patients and exploring innovative immunotherapy approaches that could lead to more effective treatments. Her background in microbiology also informs her interest in how microbial infections can influence immune regulation and cancer development. Nazila aims to contribute to the development of targeted therapies that enhance the body’s immune response against tumors, making her research both translational and clinically relevant.

Awards and Honors

Nazila Bahmaie has consistently excelled throughout her academic career, earning high honors and recognition for her academic performance. She graduated with distinction during her MSc in Medical Microbiology and Immunology, earning an A++ for her academic achievements at Zanjan University of Medical Sciences. In addition, she successfully secured a PhD fellowship in Immunology and Allergy at Near East University, showcasing her dedication and merit in the field. While specific awards and honors related to her current PhD work are not detailed, her academic trajectory and continuous involvement in research highlight her potential for future recognition in the scientific community, particularly in cancer biology and immunology.

Conclusion

Nazila Bahmaie has a solid academic foundation and promising potential, particularly in the fields of cancer biology and immunology. However, to be a strong contender for the Best Researcher Award, she would benefit from expanding her publication portfolio, demonstrating a clear impact of her research, and engaging in leadership roles. If she addresses these areas, she could emerge as a notable candidate in future award cycles.

Publication top noted

  • 📄 47D11 Antibody-Engineered Exosomes for Targeted Delivery of Remdesivir in Patients with COVID-19: Dream or Principle? (A Critical Editorial Study)
    • Authors: Daneshi, N., Esmaeilzadeh, A., Bahmaie, N.
    • Journal: Eurasian Journal of Medicine
    • Year: 2022
    • Citations: 1
  • 📄 Cell-Free Treatments: A New Generation of Targeted Therapies for Treatment of Ischemic Heart Diseases
    • Authors: Daneshi, N., Bahmaie, N., Esmaeilzadeh, A.
    • Journal: Cell Journal
    • Year: 2022
    • Citations: 3
  • 📄 Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study
    • Authors: Esmaeilzadeh, A., Bahmaie, N., Nouri, E., Hajkazemi, M.J., Rafie, M.Z.
    • Journal: International Journal of Molecular Sciences
    • Year: 2021
    • Citations: 8
  • 📄 The Clinical Efficacy of Rituximab Administration in Autoimmunity Disorders, Primary Immunodeficiency Diseases and Malignancies
    • Authors: Zian, Z., Berry, S.P.D.-G., Bahmaie, N., Khan, H., Azizi, G.
    • Journal: International Immunopharmacology
    • Year: 2021
    • Citations: 5
  • 📄 Clinical Applications of Interleukin-37: A Key Player in the Immunopathogenesis of Immune Disorders
    • Authors: Khosh, E., Bahmaie, N., Elahi, R., Esmaeilzadeh, A.
    • Journal: Iranian Journal of Allergy, Asthma and Immunology
    • Year: 2020
    • Citations: 2

 

Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Dr. Francisco Boix Giner | Immunology and Microbiology | Best Researcher Award

Clinical Immunologist, Blood Transfusion Center of the Valencian Community, Spain

Francisco José Boix Giner is a distinguished immunologist with a strong academic and professional background. Currently working at the Centro de Transfusión de la Comunidad Valenciana, he has a notable career in both clinical and research settings. Boix Giner’s expertise spans genomic characterization, immunogenetics, and biomarker validation, evidenced by his leadership in multiple research projects, including studies on leukemia, COVID-19, and organ transplantation. He earned his Ph.D. from the University of Murcia with a thesis on immunosuppressive treatment biomarkers. His professional experience includes roles at prestigious institutions such as the National Health Service Blood and Transplant and Anthony Nolan in the UK. With an h-index of 15 and substantial contributions to various research projects, Boix Giner’s work is highly regarded in the field of immunology. His research achievements reflect a deep commitment to advancing knowledge in immunogenetics and personalized medicine.

Profile

Education

Francisco José Boix Giner holds a comprehensive academic background in biomedical sciences. He earned his undergraduate degree in Biological Sciences with a specialization in Biomedicine from the University of Alicante in Spain, graduating with honors in September 2006. He further pursued advanced studies by completing a Master’s degree in Biomedical Technology and Research at the University of Murcia in September 2010, where he achieved an outstanding grade. Francisco then obtained his Ph.D. from the University of Murcia in June 2017, with a thesis focused on validating biomarkers for transplant patients undergoing immunosuppressive treatment. His doctoral work was conducted under the guidance of Manuel Muro Amador and Rocío Álvarez López, and it was awarded the highest distinction of “Sobresaliente Cum Laude.” This rigorous educational foundation has significantly contributed to his expertise and research in immunology and biomolecular sciences.

Professional Experience

Francisco José Boix Giner has accumulated extensive experience in immunology across several prestigious institutions. He currently serves as a Specialist in Immunology at the Centro de Transfusión de la Comunidad Valenciana, where he has been employed since November 2021. Previously, Boix held similar roles at the Hospital Universitario de Salamanca from June 2018 to November 2021, the National Health Service Blood and Transplant, and the Anthony Nolan Foundation in the UK, from 2013 to 2018. His career began at the Hospital Universitario Virgen de La Arrixaca, where he completed his residency in immunology. Boix’s work has involved leading and contributing to significant research projects, including genomic characterization of leukemia and studies on COVID-19 immunogenetics. His professional journey reflects a robust expertise in both clinical and research settings within the field of immunology.

Research Interest

Francisco José Boix Giner’s research interests center around immunology, with a particular focus on the genetic and molecular mechanisms underlying immune responses and transplant outcomes. His work includes characterizing genetic variations associated with immune system functions, such as the role of HLA and KIR genes in disease susceptibility and treatment responses. He has been involved in projects studying the impact of genetic markers on the resistance and relapse of leukemia, as well as the immunogenetic factors influencing COVID-19 prognosis. His research also extends to exploring biomarkers for assessing individual responses to immunosuppressive treatments in organ transplant patients. Boix Giner’s contributions aim to enhance the understanding of immune system interactions, improve diagnostic and therapeutic strategies, and advance personalized medicine in immunology and transplant science.

Research Skills

Francisco José Boix Giner possesses extensive research skills in the field of immunology and biomedicine. His expertise spans across various critical areas, including the characterization of genomic mechanisms in high-risk leukemia, the impact of HLA system on SARS-CoV-2 infections, and the identification of immune genetic variations in COVID-19 patients. Boix Giner has a proven track record in coordinating and leading significant research projects, such as those focused on biomarkers for preeclampsia and uterine growth restriction, as well as haplotypic characterization in leukemia patients. His proficiency in advanced techniques, including next-generation sequencing (NGS) and single-cell analysis, is complemented by his ability to secure and manage substantial research funding. His role in high-impact projects and collaborations with esteemed institutions highlights his skill in translating complex scientific data into actionable insights, furthering advancements in immunological research and patient care.

Award and Recognition

Francisco José Boix Giner, an esteemed immunologist, has garnered notable recognition in his field through a series of distinguished awards and accolades. He has been acknowledged for his significant contributions to the field of immunology, particularly in genomics and biomarker research. Boix Giner’s exceptional work has been recognized with multiple awards, including those for his innovative research on immune responses and transplantation. His research on the characterization of genomic mechanisms in leukemia and the validation of biomarkers in transplantation has earned him commendations from various institutions. In addition, he has received accolades for his leadership in high-impact research projects and his contributions to advancing understanding in immunogenetics and biomedicine. Boix Giner’s accolades underscore his commitment to scientific excellence and his influential role in the advancement of immunological research.

Conclusion

Francisco José Boix Giner is a well-qualified candidate for the Research for Best Researcher Award due to his extensive experience, significant contributions to immunology research, and strong academic background. To further strengthen his candidacy, focusing on increasing high-impact publications, expanding his research scope, and enhancing public engagement could be beneficial. Overall, his achievements and expertise make him a compelling candidate for the award.

Publication Top Notes

  1. Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study
    • Authors: Niño-Ramírez, J.E., Alcoceba, M., Gutiérrez-Zufiaurre, M.N., García-Sanz, R., Boix, F.
    • Year: 2024
    • Journal: HLA
  2. CD8+CD69+ and CD8+CD95+ Mediate Early Post-Transplant Acute Tubular Injury in Kidney Recipients
    • Authors: Boix, F., Jimenez-Coll, V., Legaz, I., Llorente, S., Muro, M.
    • Year: 2023
    • Journal: Frontiers in Bioscience – Landmark
    • Citations: 1
  3. Monitoring of Serological, Cellular and Genomic Biomarkers in Transplantation, Computational Prediction Models and Role of Cell-Free DNA in Transplant Outcome
    • Authors: Jimenez-Coll, V., Llorente, S., Boix, F., Legaz, I., Muro, M.
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
    • Citations: 5
  4. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
    • Authors: Bailén, R., Alenda, R., Herruzo-Delgado, B., Anguita, J., Kwon, M.
    • Year: 2023
    • Journal: Frontiers in Immunology
    • Citations: 4
  5. Identification of the novel HLA-A*23:01:01:27 allele in an acute myeloid patient and related donor
    • Authors: Bastos, M., Alcoceba, M., Chillón, M.C., García-Sanz, R., Boix, F.
    • Year: 2022
    • Journal: HLA
    • Citations: 2
  6. The age again in the eye of the COVID-19 storm: evidence-based decision making
    • Authors: Martín, M.C., Jurado, A., Abad-Molina, C., Ocaña, E., Molina, J.
    • Year: 2021
    • Journal: Immunity and Ageing
    • Citations: 7
  7. The novel HLA-DQB1*06:03:27 allele characterised by sequence-based typing in a European bone marrow donor
    • Authors: Boix, F., Chillón, M.C., García-Sánchez, S., Alcoceba, M., Marín-Rubio, L.A.
    • Year: 2021
    • Journal: HLA
    • Citations: 2
  8. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome
    • Authors: El Band, J.E.K., Llorente, S., Martinez-Garcia, P., Legaz, I., Muro, M.
    • Year: 2021
    • Journal: Current Protein and Peptide Science
    • Citations: 2
  9. Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain
    • Authors: Boix, F., Marín-Rubio, L.A., Alcoceba, M., González, M., García-Sanz, R.
    • Year: 2021
    • Journal: Human Immunology
    • Citations: 1
  10. Microrna expression changes in kidney transplant: Diagnostic efficacy of mir-150-5p as potential rejection biomarker, pilot study
    • Authors: Alfaro, R., Legaz, I., Jimenez-Coll, V., Llorente, S., Muro, M.
    • Year: 2021
    • Journal: Journal of Clinical Medicine
    • Citations: 14

 

 

Wajiha Ahmed | Immunology and Microbiology | Women Researcher Award

Posted on by ScienceFather

Ms. Wajiha Ahmed | Immunology and Microbiology | Women Researcher Award

Post Doctoral Fellow of Suzhou institute of Nano tech and Nano bionics, China.

Wajiha Ahmed is a distinguished researcher from Pakistan with a diverse background in biomaterials and biology. She earned her PhD from Zhejiang University, China, where she focused on immune regulation and wound healing using innovative biomaterials like chiral polymers and ROS-responsive nanofibers. Her Master’s research involved plant-derived silver nanoparticles for chemical sensing, showcasing her early commitment to impactful research. Wajiha’s significant contributions are reflected in her nine peer-reviewed publications in reputable journals, including ACS Biomaterials Science & Engineering and Journal of Biomedical Materials Research Part A. Currently serving as Assistant General Manager at Global Clinical Cura Pvt. Limited, she combines academic expertise with industry experience. Her research addresses critical health issues, particularly in wound healing for diabetic and infectious wounds, emphasizing her dedication to advancing medical science. Wajiha’s international experience and impactful research make her a strong candidate for the Best Researcher Award.

Profile
Education

Wajiha Ahmed’s educational journey reflects a strong foundation in biotechnology and biomedical sciences, coupled with advanced research experience in biomaterials. She earned her PhD from Zhejiang University, China, where she specialized in biomaterials with a focus on immune regulation and wound healing. Her doctoral research involved innovative projects such as developing ROS-responsive polymer nanofibers and exploring the impact of enantiomeric polylysine on inflammatory responses, showcasing her expertise in cutting-edge biomedical applications. Prior to her PhD, Wajiha completed her Master’s degree in Biomedical Sciences and Engineering from the National University of Sciences and Technology (NUST), Islamabad, Pakistan. Her Master’s thesis centered on the chemical sensing of carcinogens using plant-derived fluorescent flavonoids, demonstrating her ability to integrate biological and chemical sciences. Wajiha’s academic journey began with a Bachelor’s degree in Biotechnology from the Islamia University of Bahawalpur, Pakistan, where she gained a solid grounding in the life sciences.

Professional Experience

Wajiha Ahmed has a diverse professional background, blending academic and industry experience. She currently serves as the Assistant General Manager at Global Clinical Cura Pvt. Limited, a role she has held since January 2021, where she manages key clinical operations, contributing to the company’s strategic goals. Prior to this, Wajiha held academic positions, including as a Visiting Lecturer at Shifa Tameer-e-Millat University in Islamabad, Pakistan, from February 2016 to 2017, where she was involved in teaching and curriculum development. She also served as a Lecturer at Fazaia Intercollege Jinnah Camp in Islamabad from February 2016 to August 2017, and as a Teacher at Springfield Public School and College in Rawalpindi from March 2014 to 2015. These roles allowed her to hone her teaching skills and foster a deep commitment to education. Her professional experience reflects a solid foundation in both educational and managerial capacities.

Research Interest

Wajiha Ahmed’s research interests are deeply rooted in the interdisciplinary fields of biomaterials and biomedical engineering, with a particular focus on developing innovative solutions for wound healing and immune regulation. Her work spans the synthesis and characterization of advanced materials such as chiral polymers, ROS-responsive polymer nanofibers, and plant-derived silver nanoparticles. Wajiha is particularly interested in exploring the interactions between biomaterials and biological systems, aiming to enhance therapeutic outcomes in conditions such as diabetic wounds and chronic inflammations. Her PhD research on multifunctional drug-loaded nanofibers for smart wound healing and the immune modulation of bone marrow-derived macrophages highlights her dedication to addressing critical health challenges through material science. Additionally, her background in chemical sensing of carcinogens using plant-based materials underscores her commitment to environmental and health safety, making her research both impactful and socially relevant.

Research Skills

Wajiha Ahmed is an accomplished researcher with a robust set of skills in biomaterials and biomedical sciences. Her expertise lies in the synthesis and characterization of advanced nanomaterials, including chiral polymers and ROS-responsive polymer nanofibers, which she has applied to critical areas such as immune regulation and wound healing. Wajiha is proficient in various laboratory techniques, including nanoparticle synthesis, polymer grafting, and in vitro cellular assays. Her ability to design and conduct complex experiments is evident in her contributions to high-impact research projects. Additionally, she is skilled in data analysis and interpretation, employing advanced analytical tools to derive meaningful insights from experimental results. Wajiha’s research is also characterized by strong interdisciplinary collaboration, allowing her to integrate biological, chemical, and material science principles effectively. Her publications in reputable journals further reflect her dedication to advancing knowledge in the field of biomaterials.

 Awards and Recognition

Wajiha Ahmed has earned recognition for her exceptional contributions to the field of biomaterials and biology. Her innovative research on immune regulation, wound healing, and chemical sensing has been published in reputable journals, highlighting her impact on advancing scientific knowledge. Wajiha’s work has been acknowledged through her role as a first and co-author in multiple peer-reviewed publications, reflecting her dedication and expertise. Her international research experience, particularly during her PhD at Zhejiang University, has further solidified her reputation as a promising researcher in her field. Additionally, Wajiha’s involvement in interdisciplinary projects and her ability to address critical health challenges, such as diabetic wound healing, underscore her commitment to research that has tangible societal benefits. While she is still in the early stages of her career, her accomplishments have already positioned her as a rising star in biomaterials research, earning her respect and recognition among her peers.

Conclusion

Wajiha Ahmed is a strong candidate for the Best Researcher Award, given her significant contributions to biomaterials research, her impressive publication record, and her international research experience. To further strengthen her candidacy, she could focus on expanding her industrial collaborations and increasing her public engagement efforts. Overall, her multidisciplinary expertise and commitment to addressing societal challenges through research make her a suitable and competitive nominee for the award.

Publications Top Notes

  • Bi-layered Polyurethane Nanofiber Patches with Asymmetrical Surface Prevent Postoperative Adhesion and Enhance Cardiac Repair
    • Authors: Li, S., Ahmed, W., Wang, S., Zhu, Y., Gao, C.
    • Year: 2024
    • DOI: 10.1016/j.compositesb.2024.111668
  • Taking Chiral Polymers Toward Immune Regulation
    • Authors: Ahmed, W., Karabaliev, M., Gao, C.
    • Year: 2022
    • Citations: 6
    • DOI: 10.1002/pol.20220163
  • Influence of Enantiomeric Polylysine Grafted on Gold Nanorods on the Uptake and Inflammatory Response of Bone Marrow-Derived Macrophages in Vitro
    • Authors: Ahmed, W., Zhang, H., Gao, C.
    • Year: 2022
    • DOI: 10.1002/jbm.a.37068
  • Reactive Oxygen Species-Responsive and Scavenging Polyurethane Nanoparticles for Treatment of Osteoarthritis In Vivo
    • Authors: Zhang, H., Xiong, H., Ahmed, W., Fan, C., Gao, C.
    • Year: 2021
    • Citations: 39
    • DOI: 10.1016/j.cej.2020.128147
  • Adaptive Antibacterial Biomaterial Surfaces and Their Applications
    • Authors: Ahmed, W., Zhai, Z., Gao, C.
    • Year: 2019
    • Citations: 134
    • DOI: 10.1016/j.mtbio.2019.100017
  • Design and Applications of Cell-Selective Surfaces and Interfaces
    • Authors: Zhang, H., Zheng, X., Ahmed, W., Chen, Y., Gao, C.
    • Year: 2018
    • Citations: 35
    • DOI: 10.1021/acs.biomac.8b00492

 

Preethinie Punyakumari Jayasekara | Immunology and Microbiology | Best Researcher Award

Posted on by ScienceFather

Mrs. Preethinie Punyakumari Jayasekara | Immunology and Microbiology | Best Researcher Award

PhD student at University of New England, Australia.

Mrs. Preethinie Punyakumari Jayasekara is a distinguished researcher with a strong background in veterinary microbiology and molecular biology. She holds a PhD from the University of Reading, an MPhil from the University of Peradeniya, and a BVSc (Hons) from the University of Sri Lanka. Her professional experience spans roles as a Veterinary Research Officer at the Veterinary Research Institute of Sri Lanka, a Government Veterinary Surgeon, and extensive research periods at notable institutions in Laos and Australia. Her research interests focus on disease diagnosis in livestock, antimicrobial resistance, and microbiological quality testing. Jayasekara has authored numerous publications, including conference proceedings and review papers. Her key skills include designing and executing research methodologies, data analysis, and collaboration with various research entities. Her work has contributed significantly to advancements in animal health and production.

Profile

Education🎓

Mrs. Preethinie Punyakumari Jayasekara holds an impressive educational background in veterinary science and microbiology. She earned her Bachelor of Veterinary Science with Honours (BVSc) from the University of Sri Lanka, where she laid the foundation for her expertise in animal health. Further advancing her knowledge, she pursued a Master of Philosophy (MPhil) in Microbiology at the University of Peradeniya, Sri Lanka, completing her degree in April 2019. Her MPhil research focused on microbiological quality testing of dairy products, specifically curd and yoghurt, aligning with SLS standards. Mrs. Jayasekara’s academic journey culminated with a Doctorate (PhD) from the University of Reading, Australia. Her doctoral studies further honed her skills in molecular biology, significantly contributing to her research capabilities and expertise in diagnosing and treating animal diseases. This robust educational background underpins her distinguished career in veterinary research and microbiology.

Professional Experience 🏢

Mrs. Preethinie Punyakumari Jayasekara has a diverse and accomplished professional background in veterinary science and microbiology. She served as a Veterinary Research Officer in the Molecular Biology Division at the Veterinary Research Institute, Sri Lanka, from July 2018 to September 2021. In this role, she was responsible for establishing molecular techniques for disease diagnosis, conducting research on animal health, and improving laboratory facilities. Her responsibilities also included data analysis, knowledge transfer, and collaboration with external institutes. Prior to this, she worked as a Government Veterinary Surgeon with the Department of Animal Production and Health, Sri Lanka, from December 2015 to July 2018. Her duties involved diagnosing and treating animal diseases, performing post-mortem examinations, and conducting mobile clinics and vaccination programs. Additionally, Mrs. Jayasekara has extensive experience in molecular biology through her work at the National Animal Health Laboratory in Laos and the Elizabeth Macarthur Agricultural Institute in Australia.

Research Interests 🔬

Mrs. Preethinie Punyakumari Jayasekara’s research interests focus on veterinary microbiology and molecular biology. Her work primarily revolves around the application of molecular techniques for disease diagnosis and animal health research. She is particularly interested in utilizing molecular methods to diagnose and manage diseases affecting livestock, such as eye infections and respiratory diseases in goats. Her research also explores the microbiological quality of dairy products and antimicrobial resistance in bacteria from dairy cattle and the farm environment. Mrs. Jayasekara’s expertise includes nucleic acid extraction, PCR assays, and phylogenetic analysis, which she applies to improve animal health and production. She has contributed to the understanding of disease constraints in goat production and has been involved in diagnosing and addressing various animal health issues through advanced microbiological techniques.

Award and Honors

Mrs. Preethinie Punyakumari Jayasekara has earned recognition for her significant contributions to veterinary microbiology and molecular biology. Her work, particularly in diagnosing animal diseases and improving animal health, has been highlighted in various scientific conferences. Notably, she presented at the 9th International Conference on Sustainable Animal Agriculture for Developing Countries (SAADC2023), where she discussed topics such as the causation of pinkeye in Lao goats and the impact of diseases on goat production in Lao PDR. Her research has also been acknowledged in several proceedings and scientific journals. Additionally, she has been instrumental in advancing veterinary research through her role at the Veterinary Research Institute in Sri Lanka, where she established techniques for disease diagnosis and contributed to knowledge transfer programs. Her achievements underscore her dedication to improving animal health and advancing veterinary science.

Research Skills

Mrs. Preethinie Punyakumari Jayasekara possesses extensive research skills, primarily in veterinary microbiology and molecular biology. Her expertise includes sample collection, research planning, and methodology development. She is skilled in designing and selecting primers and probes, performing nucleic acid extraction, and conducting PCR assays. Her proficiency extends to data analysis using tools such as MS Excel, RStudio, Geneious Prime, and Mega10. Jayasekara has practical experience with agarose gel electrophoresis, PCR product purification, and phylogenesis. Additionally, she has demonstrated her ability to diagnose animal diseases and develop research techniques at institutions like the National Animal Health Laboratory in Laos and the Elizabeth Macarthur Agricultural Institute in Australia. Her work also involves collaboration with other research divisions and external organizations, contributing to knowledge transfer and advancing research in animal health and production.

Publications Top Notes 📚

 

Taher Azimi | Microbioligy | Best Researcher Award

Posted on by ScienceFather

Assist Prof Dr. Taher Azimi | Microbioligy | Best Researcher Award

Faculty member at Shiraz University of Medical Sciences, Iran.

Dr. Taher Azimi is a prominent figure in the field of Environmental Science and Policy, with a diverse background in academia, government, and consultancy. He holds a Bachelor’s degree in Environmental Science and a Master’s degree in Environmental Policy. Dr. Azimi’s professional journey has seen him actively engaged in governmental initiatives, international collaborations, and private sector consulting, all aimed at addressing environmental challenges and promoting sustainable practices. His research interests span various aspects of environmental sustainability, making him a leading authority in shaping policies and practices for a more sustainable future.

Professional Profiles:

Education:

Dr. Taher Azimi completed his Bachelor’s degree in Environmental Science from an esteemed institution, followed by a Master’s degree in Environmental Policy from a renowned university.

Professional Experience

Dr. Taher Azimi began his professional journey by engaging in governmental initiatives aimed at addressing environmental challenges. He played a pivotal role in formulating and implementing policies related to sustainable development, biodiversity conservation, and climate change mitigation. Dr. Azimi’s expertise in environmental law and regulation led to significant contributions in drafting legislation aimed at protecting natural resources and promoting eco-friendly practices in industries. His career trajectory also includes collaborations with international organizations and non-profits dedicated to environmental advocacy. He participated in various projects and campaigns focused on raising awareness about environmental issues and mobilizing action for positive change. Additionally, Dr. Azimi has provided consulting services to private sector entities, offering strategic guidance on adopting environmentally responsible practices and compliance with regulatory standards.

Research Interests

Dr. Taher Azimi’s research interests encompass a wide range of topics within the field of Environmental Science and Policy. Some of his key areas of focus include sustainable development, biodiversity conservation, climate change mitigation and adaptation, environmental law and regulation, and corporate sustainability.

Publications

  1. Prevalence of antibiotic resistance in Escherichia coli strains simultaneously isolated from humans, animals, food, and the environment: a systematic review and …
    • Authors: A Pormohammad, MJ Nasiri, T Azimi
    • Year: 2019
    • Citations: 202
  2. Advanced strategies for combating bacterial biofilms
    • Authors: JY Sharahi, T Azimi, A Shariati, H Safari, MK Tehrani, A Hashemi
    • Year: 2019
    • Citations: 113
  3. Global prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: A systematic review and meta-analysis
    • Authors: A Pormohammad, K Mehdinejadiani, P Gholizadeh, MJ Nasiri, …
    • Year: 2020
    • Citations: 83
  4. Insertional inactivation of oprD in carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in Tehran, Iran
    • Authors: A Shariati, T Azimi, A Ardebili, AS Chirani, A Bahramian, …
    • Year: 2018
    • Citations: 81
  5. Relationship of human herpes virus 6 and multiple sclerosis: a systematic review and meta‐analysis
    • Authors: A Pormohammad, T Azimi, F Falah, E Faghihloo
    • Year: 2018
    • Citations: 76
  6. Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review
    • Authors: T Azimi, M Mosadegh, MJ Nasiri, S Sabour, S Karimaei, A Nasser
    • Year: 2019
    • Citations: 72
  7. The possible role of bacteria, viruses, and parasites in initiation and exacerbation of irritable bowel syndrome
    • Authors: A Shariati, F Fallah, A Pormohammad, A Taghipour, H Safari, AS Chirani, …
    • Year: 2019
    • Citations: 69
  8. Evaluation of Nano-curcumin effects on expression levels of virulence genes and biofilm production of multidrug-resistant Pseudomonas aeruginosa isolated from …
    • Authors: A Shariati, E Asadian, F Fallah, T Azimi, A Hashemi, J Yasbolaghi Sharahi, …
    • Year: 2019
    • Citations: 68
  9. The role of bacteria in the inflammatory bowel disease development: a narrative review
    • Authors: T Azimi, MJ Nasiri, AS Chirani, R Pouriran, H Dabiri
    • Year: 2018
    • Citations: 67
  10. Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children’s Hospital, Tehran, Iran …
    • Authors: T Azimi, S Maham, F Fallah, L Azimi, Z Gholinejad
    • Year: 2019
    • Citations: 64